Stockscreener 앱 받기
9.42
3.40%
0.31
시간 외 거래:
9.52
0.10
+1.06%
전일 마감가:
$9.11
열려 있는:
$9.38
하루 거래량:
5.02M
Relative Volume:
1.39
시가총액:
$1.17B
수익:
$631.73M
순이익/손실:
$-239.78M
주가수익비율:
-4.6634
EPS:
-2.02
순현금흐름:
$-33.45M
1주 성능:
-1.15%
1개월 성능:
+16.30%
6개월 성능:
-40.64%
1년 성능:
-58.19%
1일 변동 폭
$9.21
$9.83
1주일 범위
$8.945
$9.83
52주 변동 폭
$6.78
$24.76
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
9.42 | 1.17B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
285.36 | 45.71B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.85 | 9.78B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
111.55 | 8.70B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.16 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga
Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com
10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World
ARK Investment Acquires 290K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus
10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the 31.90% Potential Upside - DirectorsTalk Interviews
Cathie Wood's ARK Investment Acquires Significant Stake in 10x G - GuruFocus
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
10 Best Healthcare Stocks to Invest In (June 2025) - Securities.io
ARK Investment Acquires 342K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus
Cetera Investment Advisers Raises Stake in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World
Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock - Investing.com
10x Genomics, Inc. (NASDAQ:TXG) Given Average Recommendation of “Hold” by Analysts - Defense World
Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance
Shareholders May Be Wary Of Increasing 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation Package - simplywall.st
10x Genomics, Inc. (TXG) Stock Analysis: A 52.56% Potential Upside Amidst a Challenging Market - DirectorsTalk Interviews
10x Genomics’ (TXG) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of America Corp DE - Defense World
Why 10x Genomics Stock Was Sliding This Week - Barchart.com
10x Genomics Reports Third Quarter 2023 Financial Results - Seeking Alpha
10x Genomics Reports First Quarter 2024 Financial Results - Seeking Alpha
Gotham Asset Management LLC Takes $264,000 Position in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World
10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
10x Genomics (NASDAQ:TXG) Price Target Lowered to $18.00 at Morgan Stanley - Defense World
10x Genomics (NASDAQ:TXG) Shares Down 4.8% Following Analyst Downgrade - Defense World
High-Throughput Transcriptomics 2025–2028: Next-Gen Breakthroughs Set to Disrupt Genomics Market - macnifico.pt
10x Genomics (TXG) Price Target Lowered by Morgan Stanley | TXG Stock News - GuruFocus
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Northern Trust Corp - Defense World
Stephens Reaffirms Overweight Rating for 10x Genomics (NASDAQ:TXG) - Defense World
'Shooting ourselves in the foot': Trump administration cuts force East Bay’s 10x Genomics into layoffs - The Business Journals
Dimensional Fund Advisors LP Sells 23,956 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World
NanoString to pay 10x Genomics $68m in global settlement - Life Sciences Intellectual Property Review
10x Genomics reaches settlement with Bruker - Medical Buyer
Stifel Financial Corp Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World
UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $12.00 - Defense World
10x Genomics Reaches $68 Million Patent Settlement With Bruker - marketscreener.com
10x Genomics Settles Litigation with Bruker Corporation - TipRanks
10x Genomics settles patent dispute with Bruker for $68 million - Investing.com
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times
All Ongoing Lawsuits Between Bruker And 10X Genomics To Be Withdrawn - marketscreener.com
Earnings Release: Here's Why Analysts Cut Their 10x Genomics, Inc. (NASDAQ:TXG) Price Target To US$12.96 - simplywall.st
10x Genomics (TXG) Price Target Reduced by UBS Amid Funding Chal - GuruFocus
Bruker and 10x Genomics settle patent dispute - Yahoo Finance
10x Genomics, Bruker Strike Deal After $31M Patent Verdict - Law360
10x Genomics (TXG) Sees Price Target Lowered by UBS | TXG Stock News - GuruFocus
UPC battle between 10x Genomics and Curio Bioscience moves to next stage - JUVE Patent
UBS Adjusts Price Target on 10x Genomics to $12 From $14, Maintains Neutral Rating - marketscreener.com
Canaccord Adjusts 10x Genomics (TXG) Price Target Citing Market Uncertainty | TXG Stock News - GuruFocus
10x Genomics (TXG) Price Target Reduced by UBS Amid Funding Challenges | TXG Stock News - GuruFocus
10x Genomics (NASDAQ:TXG) Price Target Lowered to $6.50 at The Goldman Sachs Group - Defense World
10x Genomics (NASDAQ:TXG) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group - Defense World
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
0.80%
자본화:
|
볼륨(24시간):